News tagged with peptide vaccine
Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.
Cancer
Mar 15, 2013 |
not rated yet |
0
Investigational brain cancer vaccine to be tested: Peptide vaccine targets cancer survival protein
(Medical Xpress)—A new clinical research study at Roswell Park Cancer Institute (RPCI) will test a first-of-its-kind cancer "vaccine" that may prove effective against many forms of solid-tumor cancers. The vaccine, to be ...
Cancer
Sep 28, 2012 |
not rated yet |
1
Combination peptide therapies might offer more effective, less toxic cancer treatment
Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments.
Cancer
Aug 16, 2012 |
not rated yet |
0
From genome to immune response
Being able to predict which peptides are more efficient at generating immune responses would be ideal when designing vaccination approaches. European scientists made this possible by developing state-of-the-art ...
Immunology
Aug 01, 2012 |
not rated yet |
0
Vaccine trial for Alzheimer's clears key hurdle
A vaccine which revives a promising but long-abandoned path to thwart Alzheimer's disease has cleared a key safety hurdle in human trials, researchers say.
Alzheimer's disease & dementia
Jun 07, 2012 |
5 / 5 (1) |
0
Experimental vaccine elicits robust response against both HIV and tuberculosis
Clinician researchers in China have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). An estimated 14 million people worldwide are coinfected with the two pathogens. The research is published ...
Immunology
May 22, 2012 |
5 / 5 (1) |
0
Peptide vaccine stimulates immune response in patients with breast cancer
Patients with breast cancer assigned to the HER2-based peptide vaccine AE37 had immunologic responses compared with a control group, according to 24-month results presented at the AACR Annual Meeting 2012, held here March ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Peptide vaccine shows evidence of immunological, clinical activity in children with gliomas
Peptide vaccination in children with gliomas was well tolerated with evidence of immunological and clinical responses, but some children experienced periods of immunological pseudoprogression, where tumors appeared larger ...
Cancer
Apr 03, 2012 |
4 / 5 (2) |
0
A safer vaccination for Alzheimer's disease?
The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of ...
Medical research
Oct 11, 2011 |
not rated yet |
0
Celiac disease vaccine shows promising results in Phase I trial
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
Medications
May 09, 2011 |
3.3 / 5 (3) |
0
